Found 5 matching trials
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
PHASE3This phase 3 clinical trial compares the efficacy and safety of palazestran...
Location
Clinical Trial Site
A Phase 1 Study of Oral OP-1250 in Combination With Palbociclib in HR+/HER2- Breast Cancer Patients
PHASE1This is an open-label, Phase 1b dose escalation and expansion study to dete...
Status
Active Not Recruiting
Location
Clinical Trial Site
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
PHASE3This phase 3 clinical trial compares the safety and efficacy of palazestran...
Status
Active Not Recruiting
Location
Clinical Trial Site
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
PHASE1This is a first-in-human, open-label, multicenter phase 1 study to evaluate...
Location
Florida Cancer Specialists
Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer
PHASE1This is a Phase 1b open-label, 2-part study in 3 treatment groups. The 3 tr...
Location
Banner MD Anderson Cancer Center